Showing results (1111-1120 of 1,243) with videos related to

Sort By:
Pageof 125
JAMA Cardiology|March 27, 2024
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection FractionKirsty McDowell, Toru Kondo, Atefeh Talebi, et al.
American Heart Journal|May 25, 2024
Framework of the strengths and challenges of clinically integrated trials: An expert panel reportAnthony E Peters, W Schuyler Jones, Brian Anderson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 22, 2023
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)Susanna Naggie, Aaron Milstone, Mario Castro, et al.
European Heart Journal|May 23, 2023
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialSafia Chatur, Muthiah Vaduganathan, Brian Claggett, et al.
European Journal of Heart Failure|May 22, 2023
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trialSafia Chatur, Jonathan W Cunningham, Muthiah Vaduganathan, et al.
EFSA Journal. European Food Safety Authority|February 23, 2023
Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome, Antonio F Hernandez-Jerez, Paulien Adriaanse, et al.
Human & Experimental Toxicology|May 26, 2017
Simulating real-life exposures to uncover possible risks to human health: A proposed consensus for a novel methodological approachA M Tsatsakis, D Kouretas, M N Tzatzarakis, et al.
JAMA Network Open|July 23, 2021
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical TrialsAkash Goyal, Tony Schibler, Brooke Alhanti, et al.
European Journal of Heart Failure|May 3, 2024
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fractionMingming Yang, Toru Kondo, Atefeh Talebi, et al.
Circulation. Heart Failure|October 27, 2023
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVERToru Kondo, Jawad H Butt, James P Curtain, et al.
Pageof 125